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OBJECTIVE—Obesity-associated insulin resistance is charac-
terized by a state of chronic, low-grade inﬂammation that is
associated with the accumulation of M1 proinﬂammatory macro-
phages in adipose tissue. Although different evidence explains
the mechanisms linking the expansion of adipose tissue and
adipose tissue macrophage (ATM) polarization, in the current
study we investigated the concept of lipid-induced toxicity as the
pathogenic link that could explain the trigger of this response.
RESEARCH DESIGN AND METHODS—We addressed this
question using isolated ATMs and adipocytes from genetic and
diet-induced murine models of obesity. Through transcriptomic
and lipidomic analysis, we created a model integrating transcript
and lipid species networks simultaneously occurring in adipo-
cytes and ATMs and their reversibility by thiazolidinedione
treatment.
RESULTS—We show that polarization of ATMs is associated
with lipid accumulation and the consequent formation of foam
cell–like cells in adipose tissue. Our study reveals that early
stages of adipose tissue expansion are characterized by M2-
polarized ATMs and that progressive lipid accumulation within
ATMs heralds the M1 polarization, a macrophage phenotype
associated with severe obesity and insulin resistance. Further-
more, rosiglitazone treatment, which promotes redistribution of
lipids toward adipocytes and extends the M2 ATM polarization
state, prevents the lipid alterations associated with M1 ATM
polarization.
CONCLUSIONS—Our data indicate that the M1 ATM polariza-
tion in obesity might be a macrophage-speciﬁc manifestation of
a more general lipotoxic pathogenic mechanism. This indicates
that strategies to optimize fat deposition and repartitioning
toward adipocytes might improve insulin sensitivity by prevent-
ing ATM lipotoxicity and M1 polarization. Diabetes 60:797–809,
2011
O
besity-associated insulin resistance is charac-
terized by a state of low-grade inﬂammation (1)
that affects adipocyte function (2) and is asso-
ciated with macrophage inﬁltration of adipose
tissue (3). Additional evidence exists that diet-induced obe-
sity (DIO) is associated with a switch in polarization of adi-
pose tissue macrophages (ATMs) from an anti-inﬂammatory
(M2) to a proinﬂammatory (M1) state (4,5). The pathogenic
relevance of this change in polarization is highlighted by the
speciﬁc clustering of M1 macrophages around necrotic
crown-like structures, in contrast with the randomly scat-
tered distribution of the anti-inﬂammatory M2 macrophages
within adipose tissue (6). Diphtheria toxin–induced death of
CD11c+ cells reduces crown-like structure formation and
improves insulin sensitivity (7), subsequently emphasizing
the pathogenic contribution of CD11c+ M1 macrophages to
the metabolic syndrome.
To explain the primary propolarizing events, we recently
proposed the adipose tissue expandability hypothesis (8,9),
in which the link between obesity, inﬂammation, and met-
abolic complications is directly related to the failure of
adipose tissue to expand and meet storage demands (10).
We proposed that the impaired ability of adipose tissue to
expand further and adipose dysfunction result in lipid
spillage from adipocytes, thus promoting lipid toxicity and
subsequent inﬂammation (11–13). Although indirect evi-
dence indicates that dysregulated lipid metabolism may alter
macrophage activation (13), the mechanism through which
lipids exert their metabolic effects in these cells and which
speciﬁc lipid species are involved remains unclear. On the
basis of the expandability hypothesis (14), we speculated
that obesity-induced polarization of ATMs may be another
lipotoxic manifestation of the metabolic syndrome resulting
from the ectopic accumulation of lipids in ATMs.
In this study, we investigated lipid-induced toxicity as
the pathogenic link between expansion of adipose tissue
and ATM polarization. Speciﬁcally, we studied ATMs and
adipocytes in parallel from both genetic and diet-induced
murine models of obesity at different stages of the de-
velopment of obesity and insulin resistance. Our results
indicate that M1 polarization is associated with the accu-
mulation of lipid species and the proliferation of lipid
droplets in ATMs, which then resemble vascular foam
cells. The accumulation of lipids in ATMs coincided with
the induction of gene-expression networks associated with
lipid uptake, storage, and metabolism. Our research also
reveals qualitative changes in the lipid species that ac-
cumulate in ATMs. Finally, we provide pharmacological
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ORIGINAL ARTICLEevidence that improving fat deposition in adipocytes pro-
motes changes in the partitioning of lipids toward adipo-
cytes and away from macrophages, which could prevent
the proinﬂammatory switch of ATMs in severely obese mice.
RESEARCH DESIGN AND METHODS
Animals and biochemistry. Animals were housed in a temperature-controlled
room (22°C) with a 12-h light/dark cycle. Food and water were available ad
libitum. All animal protocols used in this study were approved by the U.K.
Home Ofﬁce. C57BL6 wild-type and ob/ob mice were purchased from Harlan
(Oxon, U.K.) and placed on either a high-fat diet (45% calories from fat;
D12451, Research Diets, New Brunswick, NJ) or a standard diet (RM3, with
11.5% of calories from fat; SDS, Essex, U.K.) with or without 10 ppm rosigli-
tazone (Avandia) for the time indicated in Fig. 7.
Adipose tissue fractionation. Gonadal or subcutaneous inguinal depots
were removed after the mice were killed and then chopped thoroughly and
resuspended in 10 mL digestion solution (7 mL Hanks’ solution, 3 mL 7.5% BSA,
and 20 mg collagenase type II; Sigma). The digestion was performed at 37°C
using a shaker at 100 rpm for 20 min. After digestion, the adipocyte fraction
(ﬂoating) was isolated and the solution containing the stroma vascular frac-
tion was centrifuged at 1,500 rpm at 4°C for 5 min. The stroma vascular
fraction pellet was resuspended in 1 mL selection buffer (PBS, 2 mmol/L
EDTA, and 0.5% BSA), and the CD11b-positive cells were selected using CD11b
microbeads (Miltenyi Biotec), according to the manufacturer’s instructions.
Microarray. A total of 100 ng RNA (n = 4 per group) were biotin labeled using
the Affymetrix GeneChip whole-transcript sense target–labeling assay (Affy-
metrix, High Wycombe, U.K.) and hybridized to Affymetrix mouse gene ST1.0
arrays. Affymetrix Power Tools (15) were used to perform microarray data
normalization and preprocessing. CEL intensities where transformed using
robust multi-array average (16) and quantile normalization (17). Differential
gene expression was carried out using the limma (18) package from Bio-
conductor (http://bioconductor.org/). Gene-set analysis was carried out using
logistic regression methods (19,20), as implemented in Babelomics (http://
babelomics.org/) (21).
Flow cytometry. Fixed ATMs were incubated with BD Fc Block (BD Bio-
sciences) for 5 min, followed by incubation with Bodipy 493/503 (Invitrogen)
and/or speciﬁc monoclonal antibodies (GR1-Alexa 647, F4/80-PE-Cy7, and
CD209a-APCp, eBioscience; CD11b-PE, BD Bioscience; Ly6C-Alexa 488 and
CD206-Alexa-ﬂuor 647, Serotec; and CD11c-PE, Miltenyi Biotec). After wash-
ing, ATMs were analyzed using FACSCalibur equipped with CellQuest Pro
software (BD Biosciences). Nonspeciﬁc antibodies conjugated to the corre-
sponding ﬂuorochromes were used as negative controls, and the ﬂuorescence
threshold was set in order to have ,5% of total cells positive for ﬂuorescence.
The percentage of positive cells (on a ﬁxed number of events counted) for the
antibodies of interest was determined by the percentage of cells exceeding the
threshold obtained with nonspeciﬁc antibodies.
Lipidomic analysis. Adipocytes (5–10 mg) or ATMs (1.5–3.5 millions of cells)
were diluted with 200 mL of 0.9% NaCl (for adipocytes samples) or 50 mL PBS
buffer (for ATMs) and homogenized. The samples were subsequently extracted
and analyzed using liquid chromatography–mass spectrometry as previously
described (22).
Cell culture. Bone-marrow cells were isolated from C57BL6 males, differ-
entiated for 7 days (RPMI supplemented with 30% of L-cells, 10% FBS, and
1% penicillin and streptomycin) and plated. Cells were treated with palmitate
(500 mmol/L), palmitoleate (500 mmol/L), 0.4% endolipide (B-Braun Medical,
Boulogne, France), or vehicle (ethanol) in 0.68% fatty acid–free BSA RPMI
for 18 h.
Statistical analysis. All data were reported as means 6 SE. All datasets were
analyzed for statistical signiﬁcance using the Student t test (Microsoft Excel).
*P , 0.05; ** P , 0.01; *** P , 0.001.
RESULTS
Gene proﬁling of ATMs revealed biphasic expression
of genes associated with M2 and M1 markers, extra-
cellular matrix components, and lipid metabolism. We
ﬁrst studied ATM polarization in mice in two states:
1) early, relatively mild stages of obesity in mice with
relatively well-controlled glycemia despite insulin resis-
tance; and 2) in severely obese mice associated with in-
sulin resistance and glucose intolerance. We compared
ATMs from 5- and 16-week-old genetically obese ob/ob
mice and wild-type lean controls (Supplementary Fig. 1A–C).
These changes were consistent with time-dependent
alterations in circulating adiponectin levels (Supplemen-
tary Fig. 1D).
An Affymetrix microarray platform was used to com-
pare the gene-expression proﬁles of ATMs isolated from
fresh gonadal white adipose tissue of ob/ob mice at 5 and
16 weeks of age and their respective wild-type controls
(Fig. 1). ATMs were isolated by CD11b-MACS selection;
purity was checked by ﬂow cytometry. As shown in
Supplementary Fig. 2C, 87% of the cells were positive for
F4/80 and were therefore deﬁned as ATMs. No granulocyte
contamination was detected using the GR1 granulocyte
marker (Supplementary Fig. 2).
Gene ontology (GO) (19) and the Kyoto Encyclopedia of
Genes and Genomes (23) pathway analysis identiﬁed bi-
phasic transcriptional proﬁles for genes associated with
tissue pathways related to tissue repair/wound healing/
extracellular matrix synthesis and with cell migration/
adhesion/contraction (Fig. 1A). These pathways were in-
duced at 5 weeks in ob/ob compared with wild-type mice
(log odds ratio [LOR] .0). Conversely, they were re-
pressed in ob/ob mice relative to wild-type mice at 16
weeks (LOR ,0). Analysis of individual gene expression
represented as heat maps support the same biphasic pro-
ﬁle for genes involved in contraction (Fig. 1B) and extra-
cellular matrix/remodeling (Fig. 1C). The high level of
expression of genes involved in extracellular matrix/
remodeling is a classical feature of M2 anti-inﬂammatory
macrophages (Fig. 1D). At 5 weeks, ATMs from ob/ob mice
showed increased expression of M2 anti-inﬂammatory
macrophage markers (ARG1 and CD209e) compared with
wild-type controls, whereas the same M2 markers were
repressed in ATMs from 16-week-old ob/ob mice. In contrast,
at 16 weeks, there was increased expression of proin-
ﬂammatory M1 markers (monocyte chemoattractant pro-
tein 1 [MCP1], tumor necrosis factor [TNF]a,i n t e r f e r o n
[INF] INFb, and INFa/bR)i nob/ob ATMs. Altogether,
these data indicate that in mild obesity, ATMs express
a more M2-polarized proﬁle associated with remodeling
functions, whereas in severe obesity the expression of M2
markers decrease when M1-marker expression is induced.
Interestingly, the only pathway repressed at 5 weeks
and activated at 16 weeks, according to GO analysis,
was the positive regulation of innate immune response
(Fig. 1A).
In addition, several pathways involved in lipid metabo-
lism were differentially regulated in ob/ob ATMs compared
with wild-type ATMs. Expression of several genes involved
in lipid uptake, handling, and accumulation (fatty acid
transporter protein 1 [FATP1], CD36, adipose differentia-
tion–related protein [ADRP], and lipoprotein lipase [ LPL])
were upregulated in the ATMs of both 5- and 16-week-old
ob/ob mice but not in wild-type controls (Fig. 1E).
An anti-inﬂammatory M2 proﬁle in ATMs character-
izes mild obesity and conserved glucose tolerance. We
conﬁrmed that at 5 weeks of age, arginase 1 [ARG1] and
CD209e expression was higher in ATMs from ob/ob mice
compared with wild-type mice. Conversely, at 16 weeks of
age, ARG1 and CD209e expression was lower in ob/ob
versus wild-type ATMs (Fig. 2A). Also, we conﬁrmed that
the expression of extracellular matrix components, lam-
inin C1, collagen 1a2, collagen 4a1, and collagen 4a2, in-
creased at 5 weeks but decreased at 16 weeks, following
the biphasic pattern described previously (Fig. 2B). In
agreement with the switch from M2 to M1 proﬁles, genes
encoding the M1 markers MCP1, interferon-b,T N F - a,
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798 DIABETES, VOL. 60, MARCH 2011 diabetes.diabetesjournals.orgFIG. 1. Affymetrix microarray proﬁling of ATMs. Transcriptomic analysis of total RNA from wild-type (WT) versus ob/ob ATMs was done using
mouse gene ST1.0 Affymetrix array. A: GO pathway analysis revealed a biphasic regulation of several biological pathways upregulated. For each
functional class, the LOR of overrepresentation in ob/ob compared with wild-type mice is presented. Gray bars represent LOR at 5 weeks and black
bars at 16 weeks. Positive LOR implies overrepresentation of the functional class in ob/ob compared with wild-type mice, whereas negative LOR
implies underrepresentation of the functional class in ob/ob. All terms presented were found to be signiﬁcant at corrected P < 0.05 (see RESEARCH
DESIGN AND METHODS). B–E: The heat maps show selected groups of genes, sorted by biological function, differentially expressed when comparing wild-
type to ob/ob mice at 5 or 16 weeks. The red color represents high-normalized expression levels and the blue color represents low expression levels.
See the Supplementary Files for the complete list of genes.
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ob/ob mice in ATMs (Fig. 2C). Together, these transcrip-
tional data indicate that in early stages of positive energy
balance, ATMs have a predominantly anti-inﬂammatory M2
proﬁle and that severe obesity and insulin resistance cause
downregulation of M2-associated genes and induction of
the M1 proinﬂammatory gene repertoire.
We conﬁrmed these results in a diet induced obesity
(DIO) model. In this model, we also observed a biphasic
gene-expression proﬁle in which ARG1 was initially induced
FIG. 2. Polarization proﬁle of ATMs from ob/ob mice at 5 and 16 weeks. ATMs are isolated from perigonadal adipose tissue. The expression of anti-
inﬂammatory (M2) markers (A), the extracellular matrix component (B), and proinﬂammatory (M1) markers (C) were evaluated by quantitative
PCR using the standard curve method. The expression levels were normalized by the amount of 36B4. The bars represent the SEs and signiﬁcant
differences were as follows: *P < 0.05; **P < 0.005; ***P < 0.001. Males, n = 20 per group for 5-week-old mice and n = 16 per group for 16-week-old
mice (see RESEARCH DESIGN AND METHODS).
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after 6 months of the HFD, the development of obesity and
insulin resistance was accompanied by decreased CD209d
(M2) and increased CD11c (M1) mRNA levels.
Obesity is associated with the presence of foam-like
ATMs. Because our ATM proﬁling experiments revealed
an increase of mRNA levels of genes involved in lipid up-
take and storage, we hypothesized that ATMs may accu-
mulate lipids in severe obesity. Confocal images of ATMs
from 16-week-old ob/ob mice revealed strong lipid accu-
mulation compared with wild-type controls (Fig. 3A); this
was already visible in ATMs from 5-week-old ob/ob mice,
albeit of a smaller magnitude (Supplementary Fig. 5). As
illustrated in Fig. 3B, F4/80
+ cells from 16-week-old ob/ob
ATMs contained lipid droplets in their cytoplasm and
morphologically resembled proatherosclerotic foam cells.
We performed ﬂow cytometry analysis to further char-
acterize the CD11b-positive cell-sorted fraction and de-
termined the percentage of positive cells using a ﬁxed
threshold (see RESEARCH DESIGN AND METHODS). A total of 45%
of the ATMs from 16-week-old ob/ob mice stained for
bodipy and therefore were lipid loaded, whereas only
6% of ATMs from wild-type mice were bodipy positive
(Fig. 3C). Parallel to this increase in lipids, the percentage
of CD11c-positive cells in ATMs from obese mice was
signiﬁcantly higher (33 vs. 11%) compared with lean mice
(Fig. 3D). In contrast, the number of cells staining for the
M2 marker CD209a (which has a similar gene-expression
proﬁle to CD209d; data not shown) was lower in ob/ob
mice (47%) compared with wild-type mice (82%) (Fig. 3E).
Analysis of lipid content in ATMs with different polarized
states showed that in obese mice, 34% of the ATMs were
CD11c
+/Bodipy
high and 33% were CD209a
+/Bodipy
high
(Fig. 3F). These two populations were residual in lean
mice. In addition, ﬂow cytometry revealed that one-third of
the ATMs in obese, but not in wild-type, mice were double
positive for CD11c+/CD209a+ ATMs (Supplementary
Fig. 6B). Analysis of the lipid content of the different
ATM subtypes (CD11c+/CD209a2, CD11c+/CD209a+,
CD11c2/CD209a2,a n dC D 1 1 c 2/CD209a+) in the obese
mice (Fig. 3G) showed that 57% of the CD11c+/CD209a+
and 20% of CD11c+/CD209a2 ATMs were bodipy
high.I n
contrast, most of the CD11c2/CD209a+, which could be
considered as classically M2-polarized ATMs, were not
lipid loaded. Similar results were observed using an-
other M2 marker, CD206 (data not shown). Altogether,
our data show that in ob/ob mice, a large proportion of
ATMs are lipid loaded and positive for CD11c (M1) and
revealed the existence of a unique ATM subtype, CD11c
+/CD209a+, that in a high proportion of cases is lipid
loaded, whereas CD11c2/CD209a+ ATMs (M2) display
low bodipy levels.
Obesity induces opposite transcriptional patterns for
genes encoding key proteins in lipid metabolism
pathways in adipocytes versus ATMs. To address the
possibility of lipid repartition between adipocytes and
ATMs, we analyzed, in parallel, the expression of genes
associated with lipid metabolism in isolated adipocytes
and ATMs from 5- and 16-week-old wild-type and ob/ob
mice.
Gene-expression analysis in adipocytes showed that the
expression of peroxisome proliferator–activated receptor
(PPAR) g1 was reduced in adipocytes from 5-week-old ob/ob
mice (Fig. 4A) and further decreased at 16 weeks. The
expression of PPARg2 was unchanged at 5 weeks of age
but downregulated by 70% in adipocytes from 16-week-old
insulin-resistant ob/ob mice compared with wild-type adipo-
cytes (Fig. 4B). Similarly, expression of FATP1 (Fig. 4C)
and of LPL were downregulated at 16 weeks of age (Fig. 4E).
These results indicate progressive deterioration in the
ability of adipocytes to metabolize and store lipids in
parallel with the development of obesity and insulin
resistance.
Expression analysis of the same lipid-related genes in
ATMs showed that unlike adipocytes, expression of FATP1
increased in ob/ob mice compared with wild-type controls
(30% increase at 5 weeks and 300% increase at 16 weeks).
Furthermore, at 16 weeks, expression of CD36 increased
by 50% (Fig. 4D) and that of LPL (Fig. 4E)i n c r e a s e d
sixfold in ATMs from ob/ob mice. The expression of the
gene-encoding ADRP, a marker of lipid accumulation,
increased threefold in ob/ob ATMs at 16 weeks compared
with wild-type ATMs (Fig. 4F). Similar results were con-
ﬁrmed using the DIO model showing opposite changes in
the expression of genes associated with lipid metabolism
in ATMs and adipocytes during the development of obe-
sity (Supplementary Fig. 7). This is compatible with
a model in which the development of obesity and insulin
resistance is associated with lipid partitioning away from
adipocytes and into ATMs.
As expected in 16-week-old ob/ob insulin-resistant mice,
the expression of genes involved in the lipogenic pathway
(such as those encoding fatty acid synthase [FAS], stearyl
coenzyme A desaturase 1 [SCD1], elongation of long chain
fatty acids 6 [Elovl6], and diglyceride acyl transferase 1
[DGAT1]) decreased in adipocytes (Fig. 4G). In ATMs,
Elovl6 and DGAT1 initially increased at 5 weeks of age in
ob/ob ATMs compared with wild-type ATMs but then were
repressed at 16 weeks (Fig. 4H). FAS and SCD1 were un-
changed at 5 weeks but were repressed at 16 weeks. To-
gether, these data indicate that at 16 weeks, ob/ob ATMs
accumulate lipids mainly via activation of lipid uptake
and transport pathways. Moreover, lipogenic pathways in
these cells are inactive. These observations directed our
research toward the type of lipids accumulated in these
cells.
Lipid analyses reveal differences in chain length and
saturation of triglycerides in ATM and adipocytes.
Our confocal and gene-expression observations in the two
models of obesity indicate that increased lipid accumula-
tion and/or speciﬁc lipid species may contribute to M1
ATM polarization. We initially observed increased accu-
mulation of triglycerides (16-fold increase) and total cho-
lesterol (2-fold increase) in ATMs from 16-week-old ob/ob
mice compared with wild-type mice (Fig. 5A and B). Using
a lipidomics approach, we found a twofold increase in the
two most abundant triglyceride species, triglyceride (52:2)
and triglyceride (54:3), in ob/ob ATMs (Fig. 5C), both
formed by relatively short-chain fatty acids. However, not
all triglycerides increased; levels of triglyceride (54:6),
which is formed by polyunsaturated triglycerides, de-
creased by 40% in ob/ob compared with wild-type ATMs.
This indicates that ATMs from obese mice accumulate
more triglycerides, but these are selectively enriched for
saturated, short-chain fatty acids. Similar lipidomic analy-
sis of ob/ob adipocytes (Supplementary Fig. 9C) conﬁrmed
an increase in the most abundant triglyceride species in
comparison with wild-type adipocytes. However, unlike
ATMs, the increase in triglycerides in adipocytes was rel-
atively enriched in triglycerides containing long-chain
polyunsaturated fatty acids, such as triglyceride (56:7) and
triglyceride (58:8) (Supplementary Fig. 10).
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diabetes.diabetesjournals.org DIABETES, VOL. 60, MARCH 2011 801FIG. 3. Analysis of lipid content and polarization state of ATMs isolated from perigonadal adipose tissue from 16-week-old wild-type (WT) and ob/
ob mice. A: Representative images of ATMs taken with a confocal microscope. Bodipy (green) detects neutral lipids and DAPI (blue) dyes nucleus.
Images used 310 magniﬁcation. B: ATMs from ob/ob mice with a 340 magniﬁcation using bodipy, DAPI, and F4/80 staining (red). C–E: Flow
cytometry quantiﬁcation of lipid accumulation, CD11c+ ATMs, and CD209a+ ATMs. Filled and unﬁlled histograms represent ATMs stained with
isotype control or ﬂuorescent dye/antibodies, respectively. Panels show means 6 SE of three independent experiments with similar results. F: Dot-
plot images representing double staining (CD11c and bodipy, CD209a and bodipy) of ATMs. Images of corresponding isotype controls are shown in
Supplementary Fig. 6. G: Flow cytometry quantiﬁcation of bodipy content in different ATM subtypes from ob/ob mice. Representative data are
from three independent experiments with similar results. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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pholipid levels in ob/ob compared with wild-type ATMs.
The amount of the most abundant plasmalogen phospho-
lipid in macrophages, PE (38:4e), was lower in ob/ob ATMs
than wild-type ATMs (Fig. 5F), a trend that was also ob-
served with several other phosphatidylethanolamines (PEs),
phosphatidylcholines (PCs), and sphingomyelins (SMs)
(Fig. 5D, E, and G). Moreover, lipidomic analysis showed
FIG. 4. Change in expression levels of the lipid metabolism gene in ATMs and adipocytes. A–F: The expression proﬁle of key genes of the lipid
metabolism were analyzed in parallel in ATMs and adipocytes. The mRNA levels of genes key in the lipogenesis pathway have been quantiﬁed in
ATMs (G) and adipocytes (H). The expression levels were normalized by the amount of 36B4. The bars represent the SEs and signiﬁcant dif-
ferences were as follows: *P < 0.05; **P < 0.005; ***P < 0.001. Males, n = 16 per group (see RESEARCH DESIGN AND METHODS).
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week-old ob/ob compared with wild-type mice (Fig. 5H).
Globally considered, lipidomic analyses of ATMs showed
an increase in potentially cytotoxic lipid species (free
cholesterol, short-chain, and more saturated triglycerides)
and a depletion of protective lipids (long-chain and
polyunsaturated triglycerides and plasmalogens) in ob/ob
compared with wild-type ATMs. These changes occurred
FIG. 5. Lipidomics proﬁle of ATMs from 16-week-old ob/ob and wild-type (WT) mice. Absolute lipid concentrations of triglycerides (A) and
cholesterol (B) assessed by colorimetric method and global lipid analysis showing signiﬁcantly altered triglycerides (C), phosphotidylcholines
(D), plasmalogen (E), phosphatidylethanolamine (F), sphingomyelin (G), and free cholesterol (H). The bars represent the SE of means and
signiﬁcant differences were as follows: *P < 0.05; **P < 0.005; ***P < 0.001. Males, n = 16 per group (see RESEARCH DESIGN AND METHODS).
LIPOTOXICITY IN ADIPOSE TISSUE MACROPHAGES
804 DIABETES, VOL. 60, MARCH 2011 diabetes.diabetesjournals.orgsimultaneously with the switch in ATM polarization from
M2 to M1.
Impact of fatty acid length and saturation on
macrophage polarization state. To support the hy-
pothesis that the nature of the lipids stored might impact
ATM polarization, we treated bone-marrow differentiated
macrophages (BMDMs) with palmitate (C16), palmitoleate
(C16:1), and with endolipide, a lipidic emulsion rich in
polyunsaturated fatty acids. Our data (Fig. 6A) revealed
that although palmitate treatment reduces ARG1 (M2) ex-
pression levels, the mixture of polyunsaturated fatty acids
strongly induced its expression compared with the control.
In contrast, the expression of TNFa (M1 marker) was in-
duced by palmitate, whereas palmitoleate and endolipide
treatment reduced TNFa and MCP1 (M1 markers) expres-
sion. The expression of ADRP was similarly induced in all
three treatments, suggesting comparable lipid accumula-
tion. Finally, only unsaturated lipids induced expression of
PPARg1 and its target gene FATP1 (Fig. 6B). These results
indicate that acute lipid loading with short, saturated fatty
acids promotes M1 polarization, whereas ARG1 (M2) ex-
pression is induced by longer, more unsaturated fatty acids.
Thiazolidinedione treatment promotes and extends
M2 polarization of ATM. We investigated whether im-
proving the capacity of adipocytes to store lipid may affect
the process of polarization (24). Therefore, we treated
4-week-old ob/ob mice with a standard diet containing
10 ppm rosiglitazone (thiazolidinedione [TZD]) for 12 weeks
to assess TZD’s effect on macrophage polarization and lipid
partitioning. We conﬁrmed that TZD treatment improved
insulin sensitivity (Supplementary Fig. 8). At the same time,
analysis of gene expression in ATMs revealed that expres-
sion of the M2 anti-inﬂammatory markers ARG1, CD209d,
and CD209e markedly increased in ATMs from the TZD-
treated group compared with control ob/ob mice (Fig. 7A).
TZD treatment also reduced expression of CD11c, a marker
of proinﬂammatory ATMs, by 50% (Fig. 7B).
Reciprocal effects of TZD treatment on lipid metabolic
networks in adipocytes and ATMs. Gene expression of the
PPARg targets ADRP, FATP1,a n dLPL decreased in ATMs
from ob/ob mice treated with rosiglitazone (Fig. 7C). Con-
versely, TZD treatment upregulated expression of LPL,
FATP1,a n dCD36 in adipocytes from the rosiglitazone-treated
group (Fig. 7D). Although expression of PPARg1 in ATMs
was unaltered by rosiglitazone treatment, expression of both
PPARg1 and the more proadipogenic isoform, PPARg2,i n -
creased in adipocytes, in agreement with the TZD-mediated
increase in adipogenesis and lipid storage capacity (Fig. 7D).
Parallel lipidomic analysis revealed a marked de-
crease in ATM triglyceride levels from mice treated with
FIG. 6. BMDM treated with different types of fatty acids. BMDM are treated for 18 h with palmitate (500 mmol/L), palmitoleate (500 mmol/L), and
endolipide (0.4%). A: The expression of M2/M1 markers and of key genes of the lipid metabolism were evaluated by quantitative PCR using the
standard curve method. The expression levels were normalized by the amount of 36B4. The bars represent the SEs and signiﬁcant differences were
as follows: *P < 0.05; **P < 0.005; ***P < 0.001. Each condition has been done in triplicate (n =2 ) .
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diabetes.diabetesjournals.org DIABETES, VOL. 60, MARCH 2011 805FIG. 7. Gene-expression and lipidomic proﬁle of ATMs from ob/ob mice treated with rosiglitazone. Four-week-old male ob/ob mice (n = 7 in each
group) were fed a standard diet with (ob/ob + TZD) or without (ob/ob) 10 ppm rosiglitazone for 12 weeks. ATMs were isolated from perigonadal
adipose tissue at the end of the experiment. The expression levels of M2 markers (A), M1 markers (B), and key genes in lipid metabolism (C) were
evaluated by quantitative PCR. D: Simultaneously, expression of genes involved in different metabolic pathways was measured in the adipocyte
fraction. E: Fold change (log2) values of all the signiﬁcantly altered lipids in ATMs are represented as a heat map. The ratio of free cholesterol to
total phospholipid content (FC/PL) in (F) ob/ob vs. wild-type (WT) and (G) ob/ob vs. ob/ob TZD treated (ob/ob, n = 6; wild type, n = 3; control
ob/ob, n = 9; TZD treated ob/ob, n = 10). The bars represent the SEs and signiﬁcant differences were as follows: *P < 0.05; **P < 0.005; ***P < 0.001.
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duced by obesity in ATMs of wild-type versus ob/ob mice
and the lipid proﬁle observed in the obese model treated
with rosiglitazone revealed reciprocal effects. Speciﬁcally,
treating obese ob/ob mice with TZD decreased the two
triglycerides, triglyceride (52:2) and triglyceride (54:3),
which increased in ATMs from ob/ob mice compared with
wild-type mice (Supplementary Fig. 9C and D). TZD treat-
ment also increased concentrations of PC (36:3) and PE
(36:3), the membrane phospholipids previously shown to
decrease in ATMs from obese ob/ob mice. Furthermore, the
ratio of free cholesterol to the total phospholipid content,
an established correlate of cholesterol-induced cytotoxicity
in atherosclerotic foam cells, also showed reciprocal effects
(i.e., decreased in ATMs from TZD-treated mice compared
with control animals) (Fig. 7F and G).
DISCUSSION
Obesity is associated with subclinical inﬂammation in ad-
ipose tissue. However, it remains unclear why the expan-
sion of adipose tissue in obese individuals could attract
macrophages to this tissue and trigger their proinﬂammatory
response. In this article, we provide evidence that ATMs
from obese, insulin-resistant murine models have quantita-
tive/qualitative changes in lipid composition, which is as-
sociated with ATM polarization and the development of
low-grade inﬂammation. Using one genetic and one diet-
induced murine model of obesity, we obtained evidence
to support changes in lipid-mediated cross-talk between
adipocytes and ATMs during the progressive development
of obesity and insulin resistance. The initial phase of this
process is characterized by the induction of M2 anti-
nﬂammatory markers in ATMs and is observed in the
early stages of positive energy balance, when the adipose
tissue is actively expanding and glycemia is relatively
preserved. The M2 state is characterized by induction of
genes involved in tissue remodeling/wound healing (25).
This timing indicates that the M2 ATM phase may be a
physiological adaptation to excess nutrient availability
and adipose tissue expansion and remodeling.
The later phase is characterized by M1 ATM polariza-
tion and is associated with severe obesity and insulin re-
sistance. Additional analysis of the metabolic changes
taking place simultaneously in adipocytes and ATMs lend
support to a model in which lipid-induced toxicity is an
important determinant of the proinﬂammatory switch in
ATM polarization. Indeed, our results reveal that nearly
50% of the ATMs from obese mice accumulate lipids and
resemble proatherosclerotic foam cells. Lipid accumula-
tion was associated with increased CD11c+ ATMs (M1)
and decreased CD209a+ ATMs (M2). However we identi-
ﬁed a unique subclass of ATMs that were positive for both
CD209a+ and CD11c+ and that were in large proportion
lipid loaded. This result suggests that increased lipid load
may contribute to the transition from M2 to M1 associated
with obesity-induced insulin resistance.
Parallel analyses of ATMs and adipocytes revealed op-
posite effects on gene expression and lipid composition
of the two cell types. The lipid gene networks that were
upregulated in ATMs were downregulated in adipocytes. In
terms of lipids under positive energy balance, ATMs ac-
cumulate free cholesterol and short-chain, saturated tri-
glycerides and are depleted of antioxidant plasmalogen
phospholipids. The change in length and saturation of fatty
acids might be partially explained by the decrease in mRNA
encoding SCD1 and Elovl6 at 16 weeks of age in ob/ob mice
ATMs. We also observed reciprocal changes in the lipidome
of adipocytes from obese mice compared with lean control
mice characterized by the depletion of saturated triglyceride
species that appear to be accumulated in ATMs. These
results reveal a degree of selectivity with respect to the
ATM polarization–dependent partitioning of lipids between
adipocytes and macrophages. Furthermore, our ﬁndings
support the concept of lipid species–speciﬁc pathogenic
mechanisms promoting M1 ATM polarization and suggest
the possibility of preventing this by nutritional manipu-
lation of fatty acids. The effects of treatment of BMDM
with different fatty acid species demonstrate that long,
saturated fatty acids induced ARG1 (M2) expression and
repressed the expression of M1 markers, whereas treat-
ment with palmitate (saturated fatty acids) induced TNFa
gene expression. Through these results, we speculate that
the decrease in the expression of SCD1 and Elovl6 noted
earlier may have a direct effect on ATM polarization.
From our model, we hypothesize that increasing the
capacity of adipocytes to store lipid should either prevent
or retard the switch in ATM polarization. We used rosi-
glitazone to promote fat deposition in adipocytes. Our
results reveal that treatment with rosiglitazone increases
the expression of prolipogenic genes in adipocytes, in as-
sociation with the improvement in insulin sensitivity.
Conversely, simultaneous analysis of lipid-gene networks
in ATMs revealed decreased expression of FATPs and of
ADRP. However, although both adipocytes and macro-
phages express PPARg (26), TZD treatment only modu-
lated PPARg and its target gene expression in adipocytes.
Thus, adipocytes appear to be the main target for PPARg-
dependent effects of rosiglitazone in our murine models.
Our results indicate that rosiglitazone facilitates fat de-
position in adipocytes, sequestering it away from ATMs. In
support of this, recent evidence (27) shows that selective
activation of PPARg in adipocytes, but not in macro-
phages, is sufﬁcient for whole-body insulin sensitization
equivalent to systemic TZD treatment. This adipocentric
model of the TZD effect is supported by our lipidomic
analysis, which conﬁrms the decrease in lipid accumula-
tion in rosiglitazone-treated ATMs. The ﬁnding that TZD
decreases triglyceride and free cholesterol levels in mac-
rophages supports the link between lipid accumulation in
these cells and the switch to the proinﬂammatory M1 po-
larization state.
Our data indicate that the initial lipid-induced M2 po-
larization might contribute to physiological remodeling
of adipose tissue. Interestingly, Scherer et al. (28) have
shown that several collagen isoforms are upregulated in
a d i p o s et i s s u ef r o mob/ob mice and that deletion of col-
lagen 6 in an ob/ob background improves insulin sensi-
tivity and decreases adipose tissue inﬂammation despite
marked increases in adipocyte size. Altogether, these
ﬁndings raise the question of the importance of ATM-
mediated remodeling in the context of adipose tissue
expansion.
Finally, we observed an increase in free cholesterol
levels and FC:PL and a decrease in several phospholipid
species in lipid-loaded ATMs. Together, these alterations in
lipid content may trigger a lipotoxic cascade, as previously
described for induction of the inﬂammatory pathways and
endoplasmic reticulum stress (29). Recent ﬁndings dem-
onstrate the role of lipid-induced endoplasmic reticulum
stress in arterial-wall macrophages (30); it will be interesting
to investigate whether activation of this same pathway in
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induced obesity.
In brief, in this article we focused on the early patho-
genic events triggering the ATM polarization switch ob-
served in obesity. We reveal this to be a biphasic process:
the initial M2 proﬁle is associated with positive energy
balance and expansion of adipose tissue and is followed by
a proinﬂammatory M1 proﬁle in a context of maximal
adipose tissue expansion, insulin resistance, and metabolic
disturbance. This polarization switch is accompanied by
progressive lipid accumulation in ATMs, leading to the for-
mation of foam-like cells in adipose tissue. These observa-
tions can be integrated in a pathogenic model that includes
the concept of exhausted adipose tissue expandability and
adipocyte dysfunction that leads to lipid leakage and
repartitioning of lipids away from adipocytes into ATMs.
Cell-speciﬁc, reciprocal regulation of gene and biochemical
networks associated with lipid metabolism in adipocytes
and ATMs facilitate this process (Fig. 8). Based on this
model, and supported by our rosiglitazone experiments,
we propose that pharmacological/nutritional interventions
that either improve adipocyte function or prevent lipid-
induced ATM toxicity may provide novel therapeutic strat-
egies to uncouple obesity from its metabolic complications.
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